DIAZOXIDE Drug Patent Profile
Which patents cover Diazoxide, and what generic alternatives are available?
Diazoxide is a drug marketed by Abraxis Pharm, E5 Pharma Inc, and Novitium Pharma. and is included in three NDAs.
The generic ingredient in DIAZOXIDE is diazoxide. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diazoxide
A generic version of DIAZOXIDE was approved as diazoxide by E5 PHARMA INC on December 20th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIAZOXIDE?
- What are the global sales for DIAZOXIDE?
- What is Average Wholesale Price for DIAZOXIDE?
Summary for DIAZOXIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 43 |
| Drug Prices: | Drug price information for DIAZOXIDE |
| DailyMed Link: | DIAZOXIDE at DailyMed |
Recent Clinical Trials for DIAZOXIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Pisa | PHASE1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | PHASE1 |
| Columbia University | PHASE1 |
Medical Subject Heading (MeSH) Categories for DIAZOXIDE
Anatomical Therapeutic Chemical (ATC) Classes for DIAZOXIDE
US Patents and Regulatory Information for DIAZOXIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | DIAZOXIDE | diazoxide | INJECTABLE;INJECTION | 071519-001 | Aug 26, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| E5 Pharma Inc | DIAZOXIDE | diazoxide | SUSPENSION;ORAL | 211050-001 | Dec 20, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novitium Pharma | DIAZOXIDE | diazoxide | SUSPENSION;ORAL | 210799-001 | Jul 8, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
